TrialScientific reports2024

The substitute ENSO 16 has low impact on glucose metabolism in healthy humans: a randomized, double-blind, active-controlled, cross-over trial.

Martin Lutnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.